HERSHMAN RONNIE enters NASUS PHARMA LTD with 1.34M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 3/27/2026ACC: 0001493152-26-013384
1.34M
Baseline shares
0.00
Direct ownership
0 positions
80.99K
Derivative underlying
2 instruments
2
Security positions
1.34M indirect
Non-Derivative Holdings2
Ordinary Shares
IndirectShares owned909.16K
Ordinary Shares
IndirectShares owned429.31K
Total
1.34M indirect1.34M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 909.16K | Indirect |
| Ordinary Shares | 429.31K | Indirect |
| Total | 1.34M | 1.34M indirect |
Derivative Holdings2
Warrants
IndirectUnderlying security
Ordinary Shares
Underlying shares
17.97K
Shares owned
N/A
Exercise price
6.53
Expiration
—
Exercise window
—
Share options (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
63.02K
Shares owned
N/A
Exercise price
4.297
Expiration
—
Exercise window
—
Total
Underlying
80.99K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Indirect | Ordinary Shares | 6.53 | — | — | 17.97K | N/A |
| Share options (right to buy) Direct | Ordinary Shares | 4.297 | — | — | 63.02K | N/A |
| Total | 80.99K | 0.00 | ||||